Stability of extemporaneously prepared rosuvastatin oral suspension

Author:

Zaid Abdel Naser1,Shtayah Rania2,Qadumi Ayman2,Ghanem Mashour3,Qedan Rawan4,Daibes Marah4,Awwad Somud Abu4,Jaradat Nidal4,Kittana Naim5

Affiliation:

1. Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine

2. Department of Research and Development, Pharmacare Ltd., Ramallah, Palestine

3. Department of Regulatory Affairs, Pharmacare Ltd., Ramallah, Palestine

4. Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine

5. Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine

Abstract

Abstract Purpose The stability of an extemporaneously prepared rosuvastatin suspension stored over 30 days under various storage conditions was evaluated. Methods Rosuvastatin suspension was extemporaneously prepared using commercial rosuvastatin tablets as the source of active pharmaceutical ingredient. The organoleptic properties, dissolution profile, and stability of the formulation were investigated. For the stability studies, samples of the suspension were stored under 2 storage conditions, room temperature (25 °C and 60% relative humidity) and accelerated stability chambers (40 °C and 75% relative humidity). Viscosity, pH, organoleptic properties, and microbial contamination were evaluated according to the approved specifications. High-performance liquid chromatography was used for the analysis and quantification of rosuvastatin in selected samples. Microbiological investigations were also conducted. Results The prepared suspension showed acceptable organoleptic properties. It showed complete release of rosuvastatin within 15 minutes. The pH of the suspension was 9.8, which remained unchanged during the stability studies. The microbiological investigations demonstrated that the preparation was free of any microbial contamination. In addition, the suspension showed stability within at least the period of use of a 100-mL rosuvastatin bottle. Conclusion Extemporaneously prepared rosuvastatin 20-mg/mL suspension was stable for 30 days when stored at room temperature.

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Reference25 articles.

1. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease;Herrington;Circ Res,2016

2. Mechanisms of plaque formation and rupture;Bentzon;Circ Res,2014

3. Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease;Badimon;Eur Heart J Acute Cardiovasc Care,2012

4. Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy;Mitra;Am J Med Sci,2011

5. HDL cholesterol and protective factors in atherosclerosis;Assmann;Circulation,2004

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Stability of API as a Key Parameter for New Formulations Development - A Case Study of Rosuvastatin Calcium;Acta Poloniae Pharmaceutica - Drug Research;2023-11-21

2. Effects of Atorvastatin and Rosuvastatin on Blood Lipids in Quaker Parrots (Myiopsitta monachus);Journal of Avian Medicine and Surgery;2023-11-10

3. Stability of sulfadiazine sugar-free oral suspensions for the treatment of congenital toxoplasmosis;Brazilian Journal of Pharmaceutical Sciences;2023

4. Correction Notice;American Journal of Health-System Pharmacy;2020-09-26

5. Stability Studies of Extemporaneous Pharmaceutical Products;Drug Stability and Chemical Kinetics;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3